FURTHER PROVING OF X-RAY FIBRE DIFRACTION DIAGNOSTIC TEST FOR PROSTATE CANCER

这个子项目是利用资源的许多研究子项目之一。 由NIH/NCRR资助的中心拨款提供。对子项目的主要支持 子项目的首席调查员可能是由其他来源提供的， 包括美国国立卫生研究院的其他来源。为子项目列出的总成本可能 表示该子项目使用的中心基础设施的估计数量， 不是由NCRR赠款提供给次级项目或次级项目工作人员的直接资金。 尽管到目前为止的光纤衍射结果显示， 对于前列腺癌患者和皮肤样本结果模式的特殊变化，这项建议旨在解决以下悬而未决的问题： 1.在肿瘤生长的早期，观察到的衍射图的变化有多早？ 2.皮肤是最好的纸巾吗？ 3.手术或其他治疗成功后，这些变化会消失吗？ 4.在所有患者中观察到的纤维衍射是否有明显差异 高级别和低级别前列腺癌患者的模式？ 对任何一个或所有这些问题的肯定回答将极大地提高这项测试的有效性 都是男人。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Although fiber diffraction results to date reveal 100% correlation between the presence of prostate cancer in the patient and a particular change in the resultant pattern for skin samples, this proposal aims to address the following unresolved questions: 1. How early in the cancer growth is the change in the diffraction pattern observed? 2. Is skin the best tissue to use? 3. Do changes disappear following successful surgery or other treatments? 4. Is there a clear difference, observed for all patients, between the fibre diffraction patterns from patients with high and low grade prostate cancer? A positive answer to any or all of these would greatly enhance the usefulness of this test for all men.